BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29364266)

  • 1. Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells.
    Nanbakhsh A; Best B; Riese M; Rao S; Wang L; Medin J; Thakar MS; Malarkannan S
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells.
    Nanbakhsh A; Malarkannan S
    Methods Mol Biol; 2020; 2097():107-113. PubMed ID: 31776922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.
    Sutlu T; Nyström S; Gilljam M; Stellan B; Applequist SE; Alici E
    Hum Gene Ther; 2012 Oct; 23(10):1090-100. PubMed ID: 22779406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vectors mediate stable and efficient gene delivery into primary murine natural killer cells.
    Tran J; Kung SK
    Mol Ther; 2007 Jul; 15(7):1331-9. PubMed ID: 17505478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.
    Lin C; Zhang J
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):200-215. PubMed ID: 29378229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-efficient lentiviral vector-mediated gene transfer into primary human NK cells.
    Micucci F; Zingoni A; Piccoli M; Frati L; Santoni A; Galandrini R
    Exp Hematol; 2006 Oct; 34(10):1344-52. PubMed ID: 16982327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral gene transduction in human and mouse NK cell lines.
    Savan R; Chan T; Young HA
    Methods Mol Biol; 2010; 612():209-21. PubMed ID: 20033643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of shRNAs into primary NK cells with lentivirus.
    Kung SK
    Methods Mol Biol; 2010; 612():233-47. PubMed ID: 20033645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
    Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
    Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
    Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
    Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens.
    Boissel L; Betancur M; Lu W; Wels WS; Marino T; Van Etten RA; Klingemann H
    Leuk Lymphoma; 2012 May; 53(5):958-65. PubMed ID: 22023526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A.
    Busche A; Goldmann T; Naumann U; Steinle A; Brandau S
    Hum Gene Ther; 2006 Feb; 17(2):135-46. PubMed ID: 16454647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2.
    Mossoba ME; Walia JS; Rasaiah VI; Buxhoeveden N; Head R; Ying C; Foley JE; Bramson JL; Fowler DH; Medin JA
    Mol Ther; 2008 Mar; 16(3):607-17. PubMed ID: 18180774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity.
    Naeimi Kararoudi M; Tullius BP; Chakravarti N; Pomeroy EJ; Moriarity BS; Beland K; Colamartino ABL; Haddad E; Chu Y; Cairo MS; Lee DA
    Semin Hematol; 2020 Oct; 57(4):201-212. PubMed ID: 33256913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
    Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
    Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
    Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
    Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.
    Töpfer K; Cartellieri M; Michen S; Wiedemuth R; Müller N; Lindemann D; Bachmann M; Füssel M; Schackert G; Temme A
    J Immunol; 2015 Apr; 194(7):3201-12. PubMed ID: 25740942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.
    Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R
    Cancer Res; 1999 Jun; 59(12):2950-6. PubMed ID: 10383160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altering the specificity of NK:target cell interactions by genetic manipulation of NK receptor expression on primary mouse NK cells.
    Tran J; Mahmood S; Carlyle JR; Kung SK
    Vaccine; 2010 May; 28(22):3767-72. PubMed ID: 20338213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors.
    Schroers R; Hildebrandt Y; Hasenkamp J; Glass B; Lieber A; Wulf G; Piesche M
    Exp Hematol; 2004 Jun; 32(6):536-46. PubMed ID: 15183894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.